Oral phosphate binding agents have been used for the treatment of hyperphosphatemia in dialysis patients for decades. Their safety record was marred in the early 1980's by reports of aluminium-related ...

IMMUNIZATIONS combining diphtheria and tetanus toxoids with pertussis vaccine, using alum or aluminum hydroxide as an adjuvant, have been reported in studies by di Sant' Agnese, 1 Volk, 2 Fleming 3 ...

The efficacy of vaccines depends on the presence of an adjuvant in conjunction with the antigen. Of these adjuvants, the ones that contain aluminium, which were first discovered empirically in 1926, ...

Arun S. Wagh, Ramkumar Natarajan, Richard L. McDaniel - Energy Technology Division, Argonne National Laboratory, Argonne, Ill. Drilling Market Focus, which normally appears in the third issue of the ...

Adjuvants, also known as immunomodulators or immune enhancers, are an additive to vaccines. Adjuvants are non-specific immune enhancers that enhance or alter the type of immune response to an antigen.

The authors provide an introduction to aluminum adsorbed vaccines, review studies of antigen stability, and propose test methods for the analysis of aluminum vaccine release and stability analysis.

The problem of phosphate accumulation became apparent quite early in the history of dialysis. Soft tissue and vascular calcification could often be clearly visualised on plain x-ray because of calcium ...